Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain

Autor: ElizaBeth Grubb, Alejandra Rivas Basterra, Constancio Medrano López, Ralph Schmidt, Istvan M. Majer, Natalia García Román

Publikováno v: Health Economics Review, Vol 7, Iss 1, Pp 1-14 (2017)
Health Economics Review
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Background Respiratory syncytial virus (RSV) infection remains one of the major reasons of re-hospitalization among children with congenital heart disease (CHD). This study estimated the cost-effectiveness of palivizumab prophylaxis versus placebo, i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e37c4550519ba5ae71d3c9a008fc8e3
http://link.springer.com/article/10.1186/s13561-017-0181-3

Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland?

Autor: Mata Charokopou, Istvan M. Majer, Johan de Raad, Stefan Broekhuizen, Maarten Postma, Bart Heeg

Publikováno v: Value in Health, 18(2), 284-291. ELSEVIER SCIENCE INC

OBJECTIVES: To identify the factors that influence the Scottish Medicines Consortium (SMC) in deciding whether to accept pharmaceutical technologies for use within the Scottish health care system.METHODS: A database of SMC submissions between 2006 an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7cb99bd258415b92faad2ed11706bf1
https://research.rug.nl/en/publications/70530036-c7ab-4a2e-a0ef-5789541bcd98

Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach

Autor: Pieter van Baal, Johan P. Mackenbach, Istvan M. Majer

Publikováno v: Statistics in Medicine, 32, 1561-1571. John Wiley & Sons Ltd.

In this paper, we report a case study on a technical generalization of the Lee-Carter model, originally developed to project mortality, to forecast body mass index (BMI, kg/m2). We present the method on an annually repeated cross-sectional data set,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9217ea8cdec782a572394b91d09c2ce6
https://hdl.handle.net/1765/34965

Life Expectancy and Life Expectancy With Disability of Normal Weight, Overweight, and Obese Smokers and Nonsmokers in Europe

Autor: Anton E. Kunst, Istvan M. Majer, Johan P. Mackenbach, Wilma J. Nusselder

Publikováno v: Obesity, 19(7), 1451-1459. Wiley-Blackwell
Obesity (Silver Spring, Md.), 19(7), 1451-1459. North American Association for the Study of Obesity

The goal of this study was to estimate life expectancy (LE) and LE with disability (LwD) among normal weight, overweight, and obese smokers and nonsmokers in Western Europe. Data from four waves (1998-2001) of the European Community Household Panel (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ddc37ef7882fb54460a94578f97a663
https://doi.org/10.1038/oby.2011.46

Mortality Risk Associated With Disability: A Population-Based Record Linkage Study

Autor: Istvan M. Majer, Bart Klijs, Wilma J. Nusselder, Pieter van Baal, Johan P. Mackenbach

Publikováno v: American Journal of Public Health, 101(12), 9-15. American Public Health Association Inc.

Objectives. We assessed the association between mortality and disability and quantified the effect of disability-associated risk factors. Methods. We linked data from cross-sectional health surveys in the Netherlands to the population registry to cre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c4a695f3c9c9c228d15c572dfd335e
https://doi.org/10.2105/AJPH.2011.300361